CoV2-Spike-D614G Citations (3)

Originally described in: Rapid assessment of SARS-CoV-2 evolved variants using virus-like particles.
Syed AM, Taha TY, Tabata T, Chen IP, Ciling A, Khalid MM, Sreekumar B, Chen PY, Hayashi JM, Soczek KM, Ott M, Doudna JA Science. 2021 Nov 4:eabl6184. doi: 10.1126/science.abl6184. PubMed Journal

---

Articles Citing CoV2-Spike-D614G

Articles
Apelin as a new therapeutic target for COVID-19 treatment. Park J, Park MY, Kim Y, Jun Y, Lee U, Oh CM. QJM. 2023 Mar 27;116(3):197-204. doi: 10.1093/qjmed/hcac229. PubMed
Virus-like particle - mediated delivery of the RIG-I agonist M8 induces a type I interferon response and protects cells against viral infection. Palermo E, Alexandridi M, Di Carlo D, Muscolini M, Hiscott J. Front Cell Infect Microbiol. 2022 Dec 14;12:1079926. doi: 10.3389/fcimb.2022.1079926. eCollection 2022. PubMed
Development of novel SARS-CoV-2 viral vectors. Liu H, Liu D. Sci Rep. 2023 Aug 11;13(1):13053. doi: 10.1038/s41598-023-40370-8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.